On March 1, the National Cancer Institute will launch a new information campaign aimed at the general public and healthcare professionals to remind people of the challenges of screening.
The National Cancer Institute (INCa) will launch, on 1er next March, an information campaign for the general public and healthcare professionals to remind people of the issues related to colorectal cancer. The objectives of this new mobilization are clear. On the one hand, remember that colorectal cancer is one of the deadliest, responsible for nearly 18,000 deaths per year. On the other hand, make people aged 50 to 60 more particularly aware of the importance of screening every two years.
In this regard, INCa insists that the pathology is cured in 9 out of 10 cases when it is detected in time. Conversely, when the disease is taken at an advanced stage, the treatments are heavier and the sequelae can be significant and alter the quality of life. The screening program therefore makes it possible to have an impact on mortality and on the incidence of colorectal cancers.
And there is work to be done in this area. In fact, colorectal cancer remains the second deadliest cancer in France. And the 3rd most common in the population. In the absence of screening, this figure is explained by the fact that it does not make noise, and develops slowly and without noticeable symptoms. In France, 95% of colorectal cancers appear after 50 years.
A screening : a simple gesture that can save life
In its latest press release, INCa repeats its usual slogan: “There is an effective way to detect this cancer at an early stage: screening”. Every 2 years, 17 million women and men aged 50 to 74 are invited to see their GP for the test. Colorectal cancer immunoassay. It is indicated for people said to be “at medium risk” for whom only age is a risk factor. In this case, the doctor reminds the stakes, the limits, and gives the test to the patient, explaining how to carry it out at home. It can also be based on a video user manual available on videotestcolorectal.fr.
Finally, after sending to the laboratory, the doctor and the patient receive the results. In 96% of cases, no anomaly is detected. But in 4% of cases, a colonoscopy will be offered. It will detect any lesions of the colon or rectum and, if so, treat them. This test can also identify a polyp and remove it before it develops into cancer.
.
